Dr Camille Carroll
Associate Professor and Honorary Consultant Neurologist
Peninsula Medical School (Faculty of Health)
- Clinical trials
- Parkinson's disease
- Remote care pathways
- Neurodegenerative disease
- Health technology
Email firstname.lastname@example.org to enquire.
- Honorary Consultant Neurologist, Plymouth Hospitals NHS Trust
- National Specialty Lead for Neurodegenerative Diseases NIHR CRN
- Parkinson’s Specialty Lead and Cluster 4 Clinical Research Lead South West Peninsula CRN
- Integrated Clinical Academic Training Lead
Dr Carroll is an academic consultant neurologist. She undertook her preclinical medical training at the University of Manchester, where she also completed an intercalated PhD (1994) investigating NMDA receptor antagonists in models of Parkinson's disease (PD). She completed her clinical training at the University of Oxford in 1997 and undertook specialist neurology training in the South West and West Midlands. In 2007 Dr Carroll was awarded a Medical Research Council fellowship which allowed her to develop research interests investigating neuroprotective mechanisms in cell culture models of Parkinson's disease.
Roles on external bodies
Progressing Parkinson's interventions
Camille is a leading light in Parkinson’s disease research in the South West, particularly in clinical trials of potential therapies and in the application of technology for early disease detection and personalised care.
“Of course, you’ll never be a neurologist – you’re a woman…”
Flying in the face of gender stereotypes, while continuing to exude a kindness that has seen her change lives.
How about I ask you?
Camille discusses traditional care models and whether they fit the needs of patients today.
Dr Carroll's current research focus is on clinical trials of neuroprotective interventions in Parkinson's disease, currently being the chief investigator of a multi-centre clinical trial of simvastatin as a potential neuroprotective therapy in PD (PD-STAT). She also has an interest in the use of technology (wearable sensors and apps) for early disease detection, personalising therapy and monitoring disease progression. She has overseen the development of a PD DNA bank (2700 samples) and a regional PD clinical research register. She was appointed National Specialty Lead for Neurodegenerative Disease in 2017. She has been PD Speciality Lead, South West Peninsula CRN since April 2014, previously being joint PD Research Director for SW DeNDRoN (2010-2014). She was Chair of the Peninsula Parkinson’s Excellence Network (PenPEN) (2015-2017).
Within University Hospitals Plymouth NHS Trust, Dr Carroll leads development of the Parkinson’s disease service, which won a Parkinson's Excellence Network Award in 2017. She also leads a successful trial delivery team, overseeing a mixed portfolio of Parkinson's clinical studies - commercial and non-commercial, interventional and observational.
Key publications are highlightedJournals